Abstract
A critical appraisal and clinical application of Johnson S, Louie TJ, Gerding DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(3):345-354. doi: 10.1093/cid/ciu313
DOI
10.22237/crp/1473984449
Recommended Citation
Fouchia DD. There is a trend favoring vancomycin vs. metronidazole in treating severe C. difficile infection. Clin. Res. Pract. 2016 Sept 15;2(2):eP1082. doi: 10.22237/crp/1473984449
Included in
Bacterial Infections and Mycoses Commons, Digestive System Diseases Commons, Medical Education Commons, Pharmaceutical Preparations Commons
